0001415889-23-007206.txt : 20230503 0001415889-23-007206.hdr.sgml : 20230503 20230503161507 ACCESSION NUMBER: 0001415889-23-007206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAUKIEN FRANK H CENTRAL INDEX KEY: 0001133649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 23884141 MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 form4-05032023_080522.xml X0407 4 2023-05-01 0001109354 BRUKER CORP BRKR 0001133649 LAUKIEN FRANK H C/O BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 true true true false PRESIDENT & CEO 1 Common Stock 2023-05-01 4 S 0 74894 78.68 D 38352034 D Common Stock 2023-05-01 4 S 0 7901 79.38 D 38262287 D Common Stock 2023-05-02 4 S 0 51294 77.70 D 38210993 D Common Stock 2023-05-02 4 S 0 49476 78.27 D 38161517 D Common Stock 1046499 I By Former Spouse Common Stock 337087 I By Son Common Stock 336607 I By Daughter Common Stock 201702 I As UTMA Custodian for Son Common Stock 71728 I As UTMA Custodian for Son Common Stock 492 I By Former Spouse The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.31 to $79.30, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.31 to 79.54, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.16 to $78.155, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.16 to $78.59, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Michael Simone, Attorney-in-Fact 2023-05-03